08:22 EST Lexeo Therapeutics (LXEO) files $300M mixed securities shelf
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LXEO:
- Four new option listings and one option delisting on December 10th
- Lexeo Therapeutics Advances Cardiac Portfolio Amid Financial Report
- Lexeo Therapeutics price target raised to $23 from $21 at H.C. Wainwright
- Lexeo Therapeutics price target raised to $25 from $23 at Chardan
- Lexeo Therapeutics price target lowered to $19 from $20 at Leerink